Roivant Sciences Ltd.
ROIV· Nasdaq
ROIVRoivant Sciences Ltd.
Filed May 30, 2024 · 10-K · 60 days after period end · 0001140361-24-028145
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $9.22M | $15.15M |
| Net Income | -$151.12M | -$33.62M | -$270.06M | -$509.56M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 30, 2024 · 60 d after period end
